RxDoctor Payments Data

Julianne Maitski

Medical · Colorado Springs, CONPI 1629781281

Payments from drug & device makers

$1,117in general payments, 2019–2025

Across 39 payments — averaging $28.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$252
  • Stryker$158
  • Collegium Pharmaceutical, Inc.$139
  • Nevro Corp.$134
  • Globus Medical$112
  • Boston Scientific$85
  • plus $237 from 7 others

What the payments were for

  • Food & beverage$1,117100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,117 in reported general payments places this provider in the 70th percentile of 766 medical providers in Colorado.

See all medical providers in Colorado

Medicare billing

Part B allowed, 2024
$13,689
Medicare patients
58
Services billed
154

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl12$7,102
Buprenorphine29$4,773
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen25$1,480
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen59$1,304
Oxycodone Hcl79$1,138
Morphine Sulfate ErMorphine Sulfate43$1,001
Pregabalin58$866
Celecoxib39$679
Methocarbamol25$331
Cyclobenzaprine Hcl38$269
Tizanidine Hcl24$247
Gabapentin21$217
Atorvastatin Calcium12$57
Meloxicam13$55

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca$139$7,10212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 766 medical providers in Colorado.

Other medical in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →